Work

COMBINED IMMUNOLOGIC THERAPY WITH INTERLEUKIN-2 AND ANTI-GD-2 MONOCLONAL ANTIBODY 14.G2a INDUCES IN VIVO IMMUNOLOGIC CONDITIONS ABLE TO MEDIATE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN VITRO, IN PEDIATRIC NEUROBLASTOMA PATIENTS

Year: 1992

Type: article

Source: Journal of Immunotherapy

DOI: 10.1097/00002371-199202000-00022

Authors: J. A. Hank, J. Surfus, J. Gan, R. Hong, K. Tans, R. Reisfeld, L. Ettinger, R. Senger, P. Reynolds, S. Friedrich, M. Bauer, S. Wiersma, D. Hammond, P. M. Sondel

Institutions: Rutgers, The State University of New Jersey, Children's Hospital Los Angeles, University of Wisconsin–Madison

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005262972

FWCI:

Cites:

Cited by:

Related to: 10